Rosiglitazone-containing products (Avandia, Avandamet, and Avaglim) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board
28 September 2010
Important safety information communication from GlaxoSmithKline on the suspension of rosiglitazone-containing products (Avandia®, Avandamet®, and Avaglim®) in the European Union market.
Important Safety Information - Avandia, Avandamet, and Avaglim